Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study ; volume:7 ; number:3 ; day:12 ; month:8 ; year:2016 ; pages:561-573 ; date:9.2016
Diabetes therapy ; 7, Heft 3 (12.8.2016), 561-573, 9.2016
- Creator
-
Lak, Vincent
- Contributor
-
Svensson, Ann-Marie
Miftaraj, Mervete
Franzen, Stefan
Eliasson, Björn
SpringerLink (Online service)
- DOI
-
10.1007/s13300-016-0191-x
- URN
-
urn:nbn:de:1111-201610062518
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lak, Vincent
- Svensson, Ann-Marie
- Miftaraj, Mervete
- Franzen, Stefan
- Eliasson, Björn
- SpringerLink (Online service)
Other Objects (12)
Direct-acting antivirals and visceral leishmaniasis: a case report
Medications that interact with direct-acting oral anticoagulant exposure
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort study
A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Direct-acting antivirals and visceral leishmaniasis: a case report
Medications that interact with direct-acting oral anticoagulant exposure
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort study
A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Direct-acting antivirals and visceral leishmaniasis: a case report
Medications that interact with direct-acting oral anticoagulant exposure
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort study
A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®